Moreover, in nasopharyngeal cancer (NPC) SR-B1 was overexpressed in 75% of clinical NPC samples and all examined NPC cell lines while SR-B1 expression was lower in surrounding non-malignant epithelial cells suggesting SR-B1 as a possible biomarker of NPC (Zheng et al., 2013). The gene discussed is SCARB1; the disease is nasopharyngeal carcinoma.